ReviewClinical pharmacokinetics2026

Simulation-Based Predictions to Support the Development of a Pediatric Fixed-Dose Combination of Dolutegravir/Emtricitabine/Tenofovir Alafenamide Fumarate.

Hylke Waalewijn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.